Research Overview
Next-Generation Pain Control with Novel Stony Brook Fatty Acid Binding Protein (FABP) Inhibitors (SB-FIs)
FABP Inhibitors (SB-FIs) as New-Generation Anticancer Agents
Novel Antifungal Acylhydrazones
Sterylglucosidase Inhibitors as Novel Antifungal Agents
Next-Generation Taxoids as Potent and Efficacious Anticancer Agents
Tumor-Targeted Delivery of Highly Potent Taxoid Anticancer Agents